Csiba L, Zhussupova A S, Likhachev S A, Parfenov V A, Churyukanov M V, Guekht A B
Department of Neurology, University of Debrecen, Debrecen, Hungary.
JSC 'Astana Medical University', Astana, Kazakhstan.
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(12):100-113. doi: 10.17116/jnevro2018118121100.
A systematic review summarizes the results of studies on the efficacy of myorelaxants (tolperisone, tizanidine, thiocolchicoside or baclofen) in the treatment of acute nonspecific low back pain published up to Dec. 2017. The authors conclude that there are enough data to confirm the efficacy of myorelaxants in treatment of nonspecific low back pain, myorelaxants are recommended as monotherapy or in combination with analgesics or NSAID, the nonsedative drugs tolperisone or thiocolchicoside should be preferred.
一项系统综述总结了截至2017年12月发表的关于肌松药（托哌酮、替扎尼定、硫代秋水仙碱或巴氯芬）治疗急性非特异性腰痛疗效的研究结果。作者得出结论，有足够的数据证实肌松药在治疗非特异性腰痛方面的疗效，推荐将肌松药作为单一疗法或与镇痛药或非甾体抗炎药联合使用，应优先选择非镇静性药物托哌酮或硫代秋水仙碱。
